EP3601363
ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES
:
EP einkaleyfi: Þýðing ekki lögð inn:
30.3.2018:
15.6.2022:
18776459.2
:
29.3.2038
:
ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES
30.3.2018
15.6.2022
:
Altor BioScience Corporation:
2810 North Commerce Parkway, Miramar, Florida 33025, US
:
SHRESTHA, Niraj:
Miramar,FL 33025, US
:
LIU, Bai:
Cooper City, FL 33024, US
:
RHODE, Peter:
Miramar ,FL 33025, US
:
WONG, Hing, C.:
Weston,FL 33332, US
:
201762480339 P:
31.3.2017:
US
:
201815937493:
27.3.2018:
US
:
US2018025366:
30.3.2018
:
C07K 16/28, C07K 16/18, C07K 14/54, C07K 14/715, A61K 38/20, A61K 38/19, A61K 38/17, A61K 39/395, A61P 35/00, A61P 37/06